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Influence of clinical history on airways bacterial
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Patients with chronic tracheostomy are subject to significant bacterial colonization of the airways, a risk factor for
respiratory infections.
The aim of our study was to verify whether bacterial colonization and humoral immune response in the airways
can be influenced by the disease which led to chronic respiratory failure and tracheostomy.
Thirty-nine clinically stable outpatients with chronic tracheostomy were considered: 24 were aected by chronic
obstructive pulmonary disease (COPD) (mean age 66 years, range 54–78, M/F 19/3; months since tracheostomy 23,
range 3–62), 15 by restrictive lung disease (RLD) (12 thoracic wall deformities, three neuromuscular disease; age 57
years, range 41–72; M/F 3/12, months since tracheostomy 22, range 2–68). Recent antibiotic or corticosteroid
treatments (51 month) were among exclusion criteria.
Bacterial counts were assessed in tracheobronchial secretions with the method of serial dilutions. Identification of
bacterial strains was performed by routine methods. Albumin, IgG, A, and M were measured in airways secretions
with an immunoturbidimetric method.
No significant dierences were found between the two groups as regards either the quantitative bacterial cultures
(RLD 814, 26–42006104; COPD 759, 10–15306104 colony forming units (cfu)/ml, geometric mean, range) or
the prevalence of the main bacterial strains, (Pseudomonas species: 38 and 37%, Serratia marcescens: 31 and 23%,
Staphylococcus aureus: 14 and 6 %, Proteus species: 3 and 8%, for RLD and COPD respectively) as a percentage of
total strains isolated (RLD=26, COPD=48). Immunoglobulin levels did not show significant dierences, apart
from being higher in underweight subjects.
We conclude that in our series of stable outpatients with chronic tracheostomy, bacteria–host interaction in the
airways was not influenced by the clinical history.
Key words: chronic tracheostomy; chronic obstructive pulmonary disease; kyphoscoliosis; neuromuscular disorders;
bronchial aspirate; bacteriology; immunoglobulins.
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Patients with chronic respiratory failure may necessitate
tracheostomy after an episode of acute respiratory decom-
pensation and unsuccessful weaning. There are several
causes of chronic respiratory failure, but they can be
grouped into two main categories, i.e. primary disorders of
the lung and extrapulmonary disorders. Although various
studies have been published in the last 20 years on the
eects of chronic tracheostomy on the lower respiratoryReceived 21 April 1999 and accepted in revised form 25 November
1999.
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known about possible dierences of eect due to the clinical
history leading to tracheostomy.
We hypothesized that patients with a pulmonary disorder
may behave dierently from subjects with chronic respira-
tory failure caused by a disease not aecting airways
structures primarily. This can be important in the long-term
follow-up of these patients, and in research studies on the
interaction between airway mucosa and microbial agents.
Methods
STUDY POPULATION
Thirty-nine outpatients with chronic tracheostomy for
chronic respiratory failure were considered in a clinically
stable phase: 24 were aected by severe chronic obstructive
pulmonary disease (COPD), diagnosed according to the# 2000 HARCOURT PUBLISHERS LTD
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M/F 21/3; months since tracheostomy mean 23, range 3–62;
all former smokers, except for one current smoker;
pretracheostomy forced expiratory volume in 1 sec —
FEV1 and FEV1/forced vital capacity — FEV1/FVC —
 40 % predicted), 15 by pure restrictive lung disease
(RLD) (12 thoracic wall deformities, three neuromuscular
disease; mean age 57, range 41–72; M/F, 3/12; months since
tracheostomy mean 22, range 2–68; all non smokers; FVC
 40% predicted, FEV1/FVC  80% predicted before
tracheostomy). Recent antibiotic or corticosteroid treat-
ments (51 month prior to study) were among exclusion
criteria.
Nutritional state was assessed by calculation of body
mass index (BMI=weight/height2) (8). Serum albumin
levels and total lymphocyte counts taken as systemic
nutritional markers were in the normal range in all the
patients.
Patients with malignancies, systemic and pulmonary
disorders other than COPD were excluded.
Only steady state pharmacological treatment with
bronchodilators was admitted as well as standard treat-
ments in the case of chronic heart failure.
No signs of exacerbation (i.e. increase of cough,
expectoration and dyspnoea) were present at the moment
of inclusion. The last episode of exacerbation had been
reported more than 1 month before. None of the patients
had been hospitalized within the previous 2 months.
Each patient gave his/her signed informed consent. The
study was carried out under the supervision of the
institutional review board at the Medical Center of
Rehabilitation in Veruno, Italy.
BRONCHIAL ASPIRATES AND
PROCESSING OF SPECIMENS
Tracheobronchial secretions were mechanically aspirated
directly from the mid-part of trachea in sterile Lukens’
containers (Vygon, Ecouen, France) through a sterile
catheter inserted in a sterile inner tracheal cannula.
Aspirations were performed by the same investigator at
the same time of the day; no saline was introduced and no
repeated aspirations were necessary. The duration of each
aspiration was about 20–30 sec and the average aspiration
pressure about 20 cm H2O. Samples were made fluid with
dithiothreitol 1 M, one part per nine parts of sample, V/V,
1 h incubation at 378C.
BACTERIOLOGICAL EVALUATIONS
Bacterial counts were assessed with the method of serial
dilutions with saline (1074 to 1077 by serial 10-fold
dilutions of the original sample). The medium used was
sheep blood agar. Data are reported as colony forming
units (cfu)/ml. When a single strain is not specified, as in the
case of multiple isolations, cfu refers to the highest charge
independent of the type of bacteria isolated.
Identification of bacterial strains was performed with
routine methods: rapid ID 32 STREP for Streptococcacee,ID 32 STAPH for the genera Staphylococcus, API NH for
Neisseria, Haemophilus and Branhamella catarrhalis, ID 32
E for Enterobacteriacee and other Gram-negative rods, and
ID 32 C for yeasts (bioMe´rieux sa, Marcy-l’Etoile, F).
Anaerobe bacteria were not assessed.
BIOCHEMICAL EVALUATIONS
Proteins and protein fractions
Liquified samples were immediately frozen at 7808C and
assays were performed within 15 days. We evaluated the
levels of Albumin, IgG, IgA, IgM, C3 and C4, with a
modified immunoturbidimetric method (9) (reagent kits:
URIN-PAK immuno MICROALB for albumin; SERA-
PAK immuno for the other substances. Miles Italiana,
Cavenago Brianza, MI, Italy). The immunoturbidimetry
reaction required an incubation time of 30 min for all the
assays; the absorbance readings were performed at 340 nm
using a COMPUR M 2000 CS2 spectrophotometer (Bayer
Diagnostic-Electronic, Munchen, Germany). All samples
were tested in duplicate.
STATISTICAL ANALYSIS
Data are reported as geometric mean and range or median
and interquartile range, unless otherwise specified. Age in
the two patient groups was compared by means of the
unpaired Student’s t-test. The Mann-Whitney U test or
Student’s t-test after log-transformation, as appropriate,
were used for examining dierences between unpaired
categorical or numerical data. Frequency distributions were
compared by w2 contingency tests with continuity correc-
tion. Comparisons of biochemical data between more than
two groups were carried out with ANOVA test, and Fischer
PLSD for post-hoc comparisons.
A  95 % probability was considered to be statistically
significant. Analyses were performed using a microcompu-
ter (Macintosh LC) and Stat-view + Graphics software
(Abacus Concept).
Results
The two groups of patients diered in age, the restrictive
subjects being younger on average (57424 years,
meanSEM) than COPD ones (66014), P=0002.
Fourteen COPD and 12 RLD patients were on long-term
mechanical ventilation; 10 COPD and three RLD patients
were on long term oxygen therapy (P=029).
The distribution of nutritional categories was signifi-
cantly dierent (P=0016) due to a higher prevalence of the
overweight condition among COPD patients (five normal,
12 overweight, five obese and two underweight) and of the
underweight state among restrictive subjects (five normal,
one overweight, three obese and six underweight, according
to BMI).
No significant dierences were found between the two
groups as to either the quantitative bacterial cultures (RLD
438 M. LUSUARDI ET AL.814, 26–42006104, COPD 75.9, 10–15306104 cfuml71,
geometric mean, range) or the prevalence of the main
bacterial strains, P=059, as a percentage of total strains
isolated (RLD=26, COPD=48) (Table 1). No yeasts were
isolated.
There were on average two isolates per patient in both
groups (range 0–3 for RLD and 0–4 for COPD).
Pseudomonas species were found in 18 of the COPD and
11 of the RLD patients (P=073).
Immunoglobulin and complement fraction levels did not
show significant dierences between RLD and COPD
patients (Table 2).
Resistance towards co-trimoxazole and most aminogly-
cosides was a frequent feature in Pseudomonas aeruginosa
(73 and about 40% of strains respectively), followed by
resistance to quinolones and cefsulodine, a third generation
cefalosporin, in about 23% of cases. Serratia marcescens
showed a frequent resistance towards some of the
aminoglycosides (65% of strains), colistin (95%) and
cefsulodine (95%), with consistent results also in the case
of non b-lactamase-protected penicillins (40%). Of the
seven strains of Staphylococcus aureus, six showed resis-
tance to colistin and aztreonam, and three to piperacilline.
Considering the global case series, mechanical ventilation
vs. oxygen-therapy alone was not found to be associated
with dierences in Ig levels (data not shown) or microbial
colonization in terms of both bacterial charge and
prevalence of strains (P. aeruginosa: 20 isolates from 26
patients using ventilator, 276, 01–42006104 cfuml71, vs.
six isolates from 13 patients not using ventilators, 1083,
152–9006104 cfuml71, P=012 for isolates and P=02TABLE 1. Microbiological data in the tracheobronchial aspira
(percentage) for the four most prevalent bacterial strains. R
pulmonary disease
Isolates no. Pseudomonas species
no. (%)
Serratia
no. (%)
RLD 29 11 (38) 9
COPD 48 18 (37) 11
Total 77 29 (377) 20
Other isolates included Morganella morgani, Acinetobacter
Streptococcus A; a normal saprophitic flora was found in two p
TABLE 2. Immune biochemical data in the tracheobronchial as
(interquartile range). RLD: restrictive lung disease; COPD: chro
albumin, mg/dl IgG/alb. IgA/alb
RLD 583
(103–1131)
043
(018–118)
148
(066–35
COPD 537
(346–642)
049
(016–096)
135
(063–22for charges; S. marcescens: 12 isolates from 26 patients
using ventilator, 350, 03–16006104 cfuml71, vs. eight
isolates from 13 patients not using ventilators, 261,
40–5506104 cfuml71, P=057 for isolates and P=08
for charges). Other bacterial strains did not give significant
results and are here omitted.
No dierences were found in relation to use of heat-
moisture exchangers (Ps. aeruginosa: six isolates from 11
users, 277, 10–42006104 cfuml71, vs. 20 isolates from 28
non-users, 378, 01–10306104 cfuml71, P=053 for
isolates and P=08 for charges; S. marcescens: seven
isolates from 11 users, 285, 03–16006104 cfuml71, vs.
13 isolates from 28 non-users, 335, 298–9756104
cfuml71, P=054 for isolates and P=09 for charges).
Comparison of patient groups subdivided according to
nutritional categories showed no dierences in local
albumin levels and Ig absolute values. Ig values standar-
dized to albumin demonstrated significant variation of
IgM/albumin (P=002) and IgA/albumin (P=0048), and a
trend for variation in IgG/albumin (P=006). Post-hoc
comparisons showed these dierences to be attributable to
a significant increase of Ig/albumin levels in underweight
patients versus subjects with normal BMI.
The presence of Pseudomonas species was not associated
with significant dierences in the nutritional state (P=056
for prevalence of Pseudomonas isolates). The same finding
was true for S. marcescens (P=008).
Patients with or without Pseudomonas species in the
aspirate did not dier significantly in biochemical data, the
only exception being IgA absolute levels, which were higher
in subjects with Pseudomonas (P=005).tes, as total number of isolates and number of isolates
LD: restrictive lung disease; COPD: chronic obstructive
marcescens Staphylococcus aureus
no. (%)
Proteus species
no. (%)
(31) 4 (14) 1 (3)
(23) 3 (6) 4 (8)
(26) 7 (9) 5 (65)
baumanii, Klebsiella oxytoca, Streptococcus pneumoniae,
atients; three samples did not yield any isolates.
pirates, standardized for albumin levels. Data as median
nic obstructive pulmonary disease
. IgM/alb. C3/alb. C4/alb.
7)
005
(002–029)
006
(005–024)
001
(0004–002)
9)
005
(001–013)
006
(001–011)
001
(0–002)
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The clinical conditions leading to chronic respiratory
failure and tracheostomy can be extremely dierent.
Despite this, our data demonstrate that after tracheostomy,
bacterial colonization and local soluble immune compo-
nents do not dier according to clinical categories, i.e.,
restrictive lung disorders vs. chronic obstructive pulmonary
disease. This is even more surprising if we consider that
COPD patients without respiratory failure frequently
present bacterial colonization and exacerbations during
their clinical history (10–12). Pure restrictive patients,
although they may present with a mild functional obstruc-
tion (13), are not considered to have a gross tracheobron-
chial involvement in terms of sputum production and local
histopathology (excluding cases at risk for aspiration).
Our microbiological data are in agreement with those
published by Bartlett et al. (1) in 1978 and confirmed in
more recent studies (4,14), which also found bacterial
colonization in most if not all patients and a similar
prevalence of Gram7 bacteria, Pseudomonas species and S.
marcescens accounting for about 2/3 of all aerobe bacteria.
However our results are in disagreement with recent data
by Cabello et al., who found colonization in 38% of
patients only and M. catarrhalis and S. aureus to be the
prevalent potential pathogens. Such a discrepancy could be
attributed to methodological dierences (use of protected
specimen brushing to sample peripheral airways rather than
bronchial aspirate to sample larger airways), dierences in
patient selection (subjects undergoing laryngectomy for
cancer rather than tracheostomy for respiratory failure),
and possible local dierences in microbial flora. In other
series, S. aureus ranks first in the frequency of isolates, but
Ps. aeruginosa has been found to be the second most
frequent bacteria (5,15).
Patterns of antibiotic resistance are obviously much
influenced by local prescription criteria. The high preva-
lence of resistance to aminoglycosides reflects their frequent
use in cases associated with ‘dicult’ bacteria such as Ps.
aeruginosa. In our series, the resistance of Ps. aeruginosa to
b-lactams was not found to be important, even for non-
b-lactamase-protected agents. Of concern, however, was the
finding of resistance of some strains of Ps. aeruginosa to
quinolones, a class of recent introduction and widespread
use. Our results concerning heat–moisture exchangers were
somewhat dierent from those of Vitacca et al. (15), who
demonstrated a tendency towards lower contamination in
users, while we found no dierences in the actual level of
contamination with regard to non-users. The use of
mechanical ventilation as compared to oxygen therapy
alone did not influence tracheobronchial bacterial contam-
ination. A marginal role of respiratory equipment in
airways bacterial contamination has already been under-
lined (4).
In this study anaerobes were not assessed. Previous
studies have shown that their presence is of minor
importance in stable tracheostomized patients (1), although
other data are in disagreement (2).
Local immunoglobulin and complement levels were
similar in RLD and COPD patients. We have no ‘normal’comparative values for bronchial aspirates in our labora-
tory, but if we consider the relative Ig/albumin values in the
airways of normal or chronic bronchitis subjects obtained
with bronchoalveolar lavage (16), a marked increase of
IgA/albumin levels (about ten times) in tracheostomized
patients can be seen, the other fractions being in a
comparable order of magnitude. This can be interpreted
as a response to chronic bacterial contamination and an
adaptation mechanism by which the organism prevents
clinically important infection. It is well known that in
chronic lung infection there is an overactive response of the
immune system (17). Interestingly, it has been demon-
strated that bronchial IgA production is soon increased and
long-lasting in critically ill patients intubated and ventilated
(18). On a clinical ground, Harlid et al. demonstrated in a
population of outpatients with chronic tracheostomy, a
relatively low risk for developing respiratory tract infec-
tions, despite high levels of tracheobronchial contamination
by potential pathogen bacteria (5). Since direct interaction
between microbes and epithelial cells is necessary to initiate
infection (19), we can speculate that tracheostomized
patients probably prevent contact through a series of
mechanisms, such as increased mucus production, easier
mucus removal with mechanical aspiration, and increased
immunoglobulin secretion. Cellular defences have not been
studied so far in tracheostomized patients.
Since the nutritional state influences tracheobronchial
contamination in chronic tracheostomy, by Ps. aeruginosa
in particular (3), we subdivided the global case series
according to BMI classes. No dierences were found in the
prevalence and level of Ps. aeruginosa contamination.
However, despite the fact that albumin and Ig classes were
not significantly dierent, underweight patients showed an
increase of albumin-corrected IgM and IgA levels with
respect to subjects with normal BMI. This could be
interpreted as an augmented immune response associated
with a poor nutritional state, may be due to a higher
frequence of respiratory infections, but we have no long-
itudinal data as a direct proof.
A follow up of our case series is in progress, to evaluate
whether, despite lack of gross dierences in bacteria–host
interaction due to baseline disorders, dierences may be found
in the progression of the condition, particularly as regards
pseudomonas contamination and acute exacerbations.
In conclusion, apart from minor dierences in local
immunoglobulin levels associated with an underweight
condition or colonization by Ps. aeruginosa, our study
demonstrates that the clinical history does not influence the
bacteria–host interaction in the large airways of outpatients
with chronic tracheostomy.
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